Sorted By Test Name - Mayo Medical Laboratories

LEUC
9771
LCMS
3287
5 50.0-99.9 Strongly positive
6 > or =100 Strongly positive Reference values
apply to all ages.
Clinical References: Homburger HA: Allergic diseases. In Clinical Diagnosis and Management by
Laboratory Methods. 21st edition. Edited by McPherson RA, Pincus MR. WB Saunders, Publ, New York,
Chapter 53, Part VI, pp. 961-971, 2007
Leucine Aminopeptidase
Reference Values:
1.0-3.3 U/mL
Test Performed by: Quest Diagnostics†Nichols Institute
33608 Ortega Highway
San Juan Capistrano, CA 92690
Leukemia/Lymphoma Immunophenotyping by Flow Cytometry
Clinical Information: Diagnostic hematopathology has become an increasingly complex
subspecialty, particularly with neoplastic disorders of blood and bone marrow. While morphologic
assessment of blood smears, bone marrow smears, and tissue sections remains the cornerstone of
lymphoma and leukemia diagnosis and classification, immunophenotyping is a very valuable and
important complementary tool. Immunophenotyping hematopoietic specimens can help resolve many
differential diagnostic problems posed by the clinical or morphologic features. This test is appropriate for
hematopoietic specimens only. If your specimen is a solid tissue, order LLPT/19499
Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue.
Useful For: Evaluating lymphocytoses of undetermined etiology Identifying B- and T-cell
lymphoproliferative disorders involving blood and bone marrow Distinguishing acute lymphoblastic
leukemia (ALL) from acute myeloid leukemia (AML) Immunologic subtyping of ALL Distinguishing
reactive lymphocytes and lymphoid hyperplasia from malignant lymphoma Distinguishing between
malignant lymphoma and acute leukemia Phenotypic subclassification of B- and T-cell chronic
lymphoproliferative disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and hairy
cell leukemia Recognizing AML with minimal morphologic or cytochemical evidence of differentiation
Recognizing monoclonal plasma cells
Interpretation: Report will include a morphologic description, a summary of the procedure, the
percent positivity of selected antigens, and an interpretive conclusion based on the correlation of the
clinical history with the morphologic features and immunophenotypic results.
Reference Values:
An interpretive report will be provided.
This test will be processed as a laboratory consultation. An interpretation of the immunophenotypic
findings and correlation with the morphologic features will be provided by a hematopathologist for every
case.
Clinical References: 1. Hanson CA, Kurtin PJ, Katzman JA, et al: Immunophenotypic analysis of
peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood
1999;94:3889-3896 2. Hanson CA: Acute leukemias and myelodysplastic syndromes. In Clinical
Laboratory Medicine. Edited by KD McClatchey. Baltimore, MD, Williams & Wilkins, Inc, 1994, pp
939-969 3. Morice WG, Leibson PJ, Tefferi A: Natural killer cells and the syndrome of chronic natural
killer cell lymphocytosis. Leuk Lymphoma 2001;41(3-4):277-284 4. Langerak, van Den Beemd,
Wolvers-Tettero, et al: Molecular and flow cytometric analysis of the Vbeta repertoire for clonality
assessment in mature TCR alpha beta T-cell proliferations. Blood 2001;98(1):165-173
Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 1105